Express report: pharmaceutical prime vendor (PPV)FY2026 july

Ended Awarded Last action

Contract number
36C24026K1010
Awardee
Awarding agency
Obligated
$1,194,619,137

Award facts

Contract value 100% obligated
$1,194,619,137.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Irving, TX 75039, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

McKesson Corporation received a delivery order on July 1, 2026, under the Pharmaceutical Prime Vendor (PPV) program for FY2026, with a ceiling value of $1,194,619,137.20 and an ultimate completion date of July 31, 2026. The order was issued by a civilian federal agency and carries firm fixed pricing with no set-aside designation.

Place of performance is Irving, TX. The delivery order supplies pharmaceutical products and medical materials to federal healthcare operations and facilities nationwide through the PPV program infrastructure.

Quick answers

Who was awarded contract 36C24026K1010?

36C24026K1010 was awarded to Mckesson Corporation by Headquarters (Department of Veterans Affairs) on July 1, 2026.

How much is contract 36C24026K1010 worth?

The government has obligated $1,194,619,137 on 36C24026K1010.

Is contract 36C24026K1010 an order under another contract?

Yes. 36C24026K1010 is a delivery order under 36W79720D0001, an indefinite delivery contract.

Was contract 36C24026K1010 competed?

The extent of competition for 36C24026K1010 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login